Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGIODAPT: Angiolite Stent and Abbreviated DAPT in Coronary Artery Disease
NCT05952206Phase 3Active, not recruiting
- Sponsor
- iVascular
- Start
- Oct 2023
- Primary completion
- Jan 2027
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial (4 arms), sponsored by iVascular. Primary endpoints: Target Lesion Failure at 1 year and Clinically relevant bleeding events (BARC 2, 3, or 5) at 1 year. Started Oct 2023; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05952206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05952206.